Occudo Quantitative Strategies LP Boosts Position in BrightSpring Health Services, Inc. (NASDAQ:BTSG)

Occudo Quantitative Strategies LP boosted its stake in shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG - Free Report) by 169.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 53,904 shares of the company's stock after buying an additional 33,863 shares during the quarter. Occudo Quantitative Strategies LP's holdings in BrightSpring Health Services were worth $918,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. FMR LLC lifted its stake in BrightSpring Health Services by 21.6% in the fourth quarter. FMR LLC now owns 22,102,490 shares of the company's stock worth $376,405,000 after acquiring an additional 3,933,303 shares during the last quarter. T. Rowe Price Investment Management Inc. acquired a new stake in BrightSpring Health Services during the fourth quarter worth approximately $26,958,000. Norges Bank acquired a new stake in BrightSpring Health Services during the fourth quarter worth approximately $26,065,000. Raymond James Financial Inc. acquired a new stake in BrightSpring Health Services during the fourth quarter worth approximately $18,257,000. Finally, Integral Health Asset Management LLC increased its holdings in shares of BrightSpring Health Services by 90.0% in the 4th quarter. Integral Health Asset Management LLC now owns 950,000 shares of the company's stock valued at $16,178,000 after acquiring an additional 450,000 shares during the period.

BrightSpring Health Services Trading Down 1.0%

NASDAQ:BTSG traded down $0.25 on Monday, reaching $24.18. The stock had a trading volume of 312,388 shares, compared to its average volume of 1,409,257. The company has a market cap of $4.21 billion, a price-to-earnings ratio of -92.94 and a beta of 2.06. The company has a debt-to-equity ratio of 1.63, a current ratio of 1.35 and a quick ratio of 0.97. The firm's fifty day moving average is $18.59 and its two-hundred day moving average is $19.02. BrightSpring Health Services, Inc. has a 12-month low of $10.15 and a 12-month high of $24.82.

BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last released its earnings results on Friday, May 2nd. The company reported $0.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.09 by $0.10. The company had revenue of $2.88 billion for the quarter, compared to analyst estimates of $2.74 billion. BrightSpring Health Services had a negative net margin of 0.38% and a positive return on equity of 4.16%. The firm's quarterly revenue was up 25.9% on a year-over-year basis. During the same period in the prior year, the firm earned $0.12 EPS. Equities analysts expect that BrightSpring Health Services, Inc. will post 0.59 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have issued reports on BTSG shares. Morgan Stanley boosted their price objective on shares of BrightSpring Health Services from $20.00 to $25.00 and gave the company an "overweight" rating in a research note on Friday, May 9th. Mizuho set a $26.00 target price on shares of BrightSpring Health Services in a research report on Monday, May 5th. UBS Group boosted their target price on shares of BrightSpring Health Services from $22.00 to $30.00 and gave the stock a "buy" rating in a research report on Wednesday, January 29th. Finally, Wells Fargo & Company boosted their target price on shares of BrightSpring Health Services from $25.00 to $27.00 and gave the stock an "overweight" rating in a research report on Tuesday, May 13th. One research analyst has rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $23.56.

BrightSpring Health Services Profile

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.